The ε3-ε4 genotype had an increasing trend, accounting for 11.2% in the control group, 19.6% in the CHD group and 24.9% in the CHD-IS group, respectively.
← all excerpts
Association of <i>Apolipoprotein E</i> Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins.
1
—
—